Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.
NCT00151645
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Renal Cell Carcinoma
Interventions
DRUG:
activated lymphocytes
Sponsor
Rennes University Hospital
Collaborators
[object Object]